Sandbox Reserved 957: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
* The Me-1 and Me-2 sites are occupied by metal ions, Zinc within Me-1 and within Me-2, Zinc, Magnesium or Manganese <ref>[5]</ref>,<br \> | * The Me-1 and Me-2 sites are occupied by metal ions, Zinc within Me-1 and within Me-2, Zinc, Magnesium or Manganese <ref>[5]</ref>,<br \> | ||
* The residues <scene name='60/604476/His617_asp654_asp764_his653/1'>His617, Asp654, Asp764, His653</scene> and two H2O (W1 et W2) binding zinc:<br \> | * The residues <scene name='60/604476/His617_asp654_asp764_his653/1'>His617, Asp654, Asp764, His653</scene> and two H2O (W1 et W2) binding zinc:<br \> | ||
** The crucial <scene name='60/604476/Asp764/1'>Asp764</scene> [3] and the conserved His617 and 653[4], which bind one Zinc ion, are fundamental for the catalytic activity.<br \> | ** The crucial <scene name='60/604476/Asp764/1'>Asp764</scene> <ref>[3]</ref> and the conserved His617 and 653<ref>[4]</ref>, which bind one Zinc ion, are fundamental for the catalytic activity.<br \> | ||
** <scene name='60/604476/Zn/1'>Zinc</scene> is critical for catalytic activity, but it isn't implied in the formation of the hydrophobic pocket. In fact, even if <scene name='60/604476/His653_his617/1'>the His617and 653</scene> are lost and so the Zn not bound, a massive addition of Manganese[4] in the medium allows a reactivation of catalysis.<br \> | ** <scene name='60/604476/Zn/1'>Zinc</scene> is critical for catalytic activity, but it isn't implied in the formation of the hydrophobic pocket. In fact, even if <scene name='60/604476/His653_his617/1'>the His617and 653</scene> are lost and so the Zn not bound, a massive addition of Manganese<ref>[4]</ref> in the medium allows a reactivation of catalysis.<br \> | ||
* W2 binds <scene name='60/604476/Mg_zn/1'>Zn and Mg</scene> [24],<br \> | * W2 binds <scene name='60/604476/Mg_zn/1'>Zn and Mg</scene> <ref>[24]</ref>,<br \> | ||
* And there are 3 hydrogen bonds between 3 H2O and the conserved resides <scene name='60/604476/His657glu682his685/1'>His657, Asp682 and His685</scene> [24].<br \> | * And there are 3 hydrogen bonds between 3 H2O and the conserved resides <scene name='60/604476/His657glu682his685/1'>His657, Asp682 and His685</scene> <ref>[24]</ref>.<br \> | ||
Q site contains:<br \> | Q site contains:<br \> | ||
* In particular the conserved residues <scene name='60/604476/Qsite1/1'>Gln817, Phe820, Val782 and Tyr612. [24]</scene><br \> | * In particular the conserved residues <scene name='60/604476/Qsite1/1'>Gln817, Phe820, Val782 and Tyr612. <ref>[24]</ref></scene><br \> | ||
* The hydrogen bonds, between <scene name='60/604476/Qsite2/1'>Gln817 and 775, Gln775 and Ala767, Gln775 and Trp853</scene>, imply an interaction between <scene name='60/604476/Gln817/1'>Gln817</scene> and the cGMP purine. Thus, it improves the specificity for the cGMP, against cAMP. [24]<br \> | * The hydrogen bonds, between <scene name='60/604476/Qsite2/1'>Gln817 and 775, Gln775 and Ala767, Gln775 and Trp853</scene>, imply an interaction between <scene name='60/604476/Gln817/1'>Gln817</scene> and the cGMP purine. Thus, it improves the specificity for the cGMP, against cAMP. <ref>[24]</ref><br \> | ||
* And <scene name='60/604476/Qsite3/1'>Tyr612, Val782, Leu785 an Phe820</scene> bind the cGMP through this pyrazol ring and π-π interactions between Gln817 and the phenyl ring. [24]<br \> | * And <scene name='60/604476/Qsite3/1'>Tyr612, Val782, Leu785 an Phe820</scene> bind the cGMP through this pyrazol ring and π-π interactions between Gln817 and the phenyl ring. <ref>[24]</ref><br \> | ||
** So, the conserved hydrophobic residue <scene name='60/604476/Tyr612/1'>Tyr 612</scene> is critical in the maintaining of the affinity. [3]<br \> | ** So, the conserved hydrophobic residue <scene name='60/604476/Tyr612/1'>Tyr 612</scene> is critical in the maintaining of the affinity. <ref>[3]</ref><br \> | ||
H site:<br \> | H site:<br \> | ||
* In particular the residues <scene name='60/604476/Hsite1/1'>Phe786, Ala783, Leu804, Val782</scene>. [24]<br \> | * In particular the residues <scene name='60/604476/Hsite1/1'>Phe786, Ala783, Leu804, Val782</scene>. <ref>[24]</ref><br \> | ||
L site:<br \> | L site:<br \> | ||
* In particular the hydrophobic residues <scene name='60/604476/Lsite1/1'>Tyr664, Met816, Ala823, Gly819</scene>. [24]<br \> | * In particular the hydrophobic residues <scene name='60/604476/Lsite1/1'>Tyr664, Met816, Ala823, Gly819</scene>. <ref>[24]</ref><br \> | ||
Besides, the kcat of the catalytic fragment decreases 40-fold and 8-fold if the residues <scene name='60/604476/Lys603_leu644/1'>His603 and Asp644</scene> are mutated, and so there are important in the catalytic activity [5 | Besides, the kcat of the catalytic fragment decreases 40-fold and 8-fold if the residues <scene name='60/604476/Lys603_leu644/1'>His603 and Asp644</scene> are mutated, and so there are important in the catalytic activity <ref>[5][3]</ref>. Two others residues are significant: <scene name='60/604476/Gln778/1'>the Gln778</scene> which is important for cGMP affinity but have no impact on cAMP affinity H-loop <ref>[8]</ref> and the conserved <scene name='60/604476/Gly659/1'>Gly659</scene> which is important for substrate affinity and catalytic activity because it determinates H-loop conformation <ref>[21]</ref> (see below).<br \> | ||
H-loop is important in the substrate recognition and the interactions with, it is <scene name='60/604476/H_loop/1'>from 660th to 693th residues</scene>. H-loop has the same interactions with cGMP and Sildenafil (cf. Inhibitor) because it's related to its role of substrate binding[21]. But The H-loop is not well understood, because when it's modified, the enzyme's function is practically not modified.[7] But it also may have a role for inhibitor fixation.<br \> | H-loop is important in the substrate recognition and the interactions with, it is <scene name='60/604476/H_loop/1'>from 660th to 693th residues</scene>. H-loop has the same interactions with cGMP and Sildenafil (cf. Inhibitor) because it's related to its role of substrate binding<ref>[21]</ref>. But The H-loop is not well understood, because when it's modified, the enzyme's function is practically not modified.<ref>[7]</ref> But it also may have a role for inhibitor fixation.<br \> | ||
Nowadays catalysis mechanism is not well know: there could be a, nucleophile attack of a water molecule on the substrate [6]. | Nowadays catalysis mechanism is not well know: there could be a, nucleophile attack of a water molecule on the substrate <ref>[6]</ref>. | ||
== Inhibition == | == Inhibition == | ||
In the treatment erection dysfunction, the inhibitors Sildenafil, Vardenafil and Tadalafil are used, like in the pulmonary hypertension[6]. Sildenafil may cure sleeping trouble after a intercontinental travel [11], may help to recover neural liaisons after an injury (the motor function[12] and the sensory motor function[13]) and can be vascular effects.<br \>[[Image:Sildenafil.jpg|center|thumb|100px|Sildenafil Inhibitor, R1 in blue, R2 in green and R3 in red]] | In the treatment erection dysfunction, the inhibitors Sildenafil, Vardenafil and Tadalafil are used, like in the pulmonary hypertension<ref>[6]</ref>. Sildenafil may cure sleeping trouble after a intercontinental travel <ref>[11]</ref>, may help to recover neural liaisons after an injury (the motor function<ref>[12]</ref> and the sensory motor function<ref>[13]</ref>) and can be vascular effects.<br \>[[Image:Sildenafil.jpg|center|thumb|100px|Sildenafil Inhibitor, R1 in blue, R2 in green and R3 in red]] | ||
* PDE5 inhibitors might help physical condition in Duchene muscular dystrophy[14], improve of cognitive function [9]and have antidepressant effect[10] , also they might have an artero[15] and endothelial cell protective effect[16] so they have cardiac protection effect[17] (controversial, cf. clinical trial “RELAX”), finally they slow tumer cell growth (Tadalafil-like)[18]<br \> | * PDE5 inhibitors might help physical condition in Duchene muscular dystrophy<ref>[14]</ref>, improve of cognitive function <ref>[9]</ref>and have antidepressant effect<ref>[10]</ref> , also they might have an artero<ref>[15]</ref> and endothelial cell protective effect<ref>[16]</ref> so they have cardiac protection effect<ref>[17]</ref> (controversial, cf. clinical trial “RELAX”), finally they slow tumer cell growth (Tadalafil-like)[18]<br \> | ||
* There are other PDE5 inhibitors: IBMX, Icarisid II and Udenafil.<br \> | * There are other PDE5 inhibitors: IBMX, Icarisid II and Udenafil.<br \> | ||
* No interaction between the M site and the inhibitors<br \> | * No interaction between the M site and the inhibitors<br \> | ||